Evolva Holding SA

Company Snapshot

Founded: 2004
Entity Type: Private
Region: Switzerland
Headquarter: Reinach, Switzerland
Corporate Address: Duggingerstrasse 23 CH-4153 Reinach Switzerland Tel. +41-61-485-2000 www.evolva.com

Company Overview

Evolva, formerly Allylix, has developed proprietary technology that allows it to produce a group of natural products called “terpenes” at a low cost. Terpenes have significant commercial value to the flavor and fragrance, insect repellent and pharmaceutical industries.

Evolva initially focused on a class of terpenes called “sesquiterpenes,” which are part of the $2-billion aroma chemical segment of the flavor and fragrance market. Evolva’s technology utilizes metabolically engineered S. cerevisiae yeast expressing sesquiterpene synthases to produce sesquiterpenes.

Evolva has identified numerous sesquiterpene flavors and fragrances whose markets would expand substantially if there were low-cost alternatives. Evolva’s first two products are the grapefruit flavor nootkatone and the orange flavor valencene, which went on the market in December 2010.

Evolva also plans to develop four sesquiterpene fragrances that are highly valued by perfumers but have Ltd. use due to their high prices. The company plans to produce these six important fragrances at a cost that will allow them to be used in household and personal care products.

In the long term, Evolva will explore the potential to capture value from its technology in the pharmaceutical market through sales of novel pharmaceutical intermediates or the development of new drugs.

Evolva Holding SA In Reports

Microbial Products: Technologies, Applications and Global Markets

BCC Research Market Report says microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a CAGR of 7.4%.

Biorefinery Products: Global Markets

BCC Research Market Analysis Report says Biorefinery Industry is estimated to increase from $624.7 bln in 2022 to $920.0 bln by 2027, at a CAGR of 8.0%.

Synthetic Biology: Global Markets

BCC Research Market Report for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate of 28.4%

Applications/End User Industries

  • Biotechnology
  • Nutrition
  • Health and Wellness
  • Technology Services
  • Health Protection
AI Sentiment